Medical Transcription Billing Stock Price, News & Analysis (NASDAQ:MTBC)

+0.09 (+2.19 %)
(As of 09/24/2019 05:46 AM ET)
Today's Range
Now: $4.20
50-Day Range
MA: $4.50
52-Week Range
Now: $4.20
Volume21,745 shs
Average Volume52,317 shs
Market Capitalization$50.54 million
P/E RatioN/A
Dividend YieldN/A
Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company's offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform. Read More…

Industry, Sector and Symbol

Industry Prepackaged software
Current SymbolNASDAQ:MTBC



Sales & Book Value

Annual Sales$50.55 million
Cash Flow$0.0694 per share
Book Value$3.29 per share


Net Income$-2,140,000.00


Market Cap$50.54 million
Next Earnings Date11/6/2019 (Estimated)
OptionableNot Optionable

Receive MTBC News and Ratings via Email

Sign-up to receive the latest news and ratings for MTBC and its competitors with MarketBeat's FREE daily newsletter.

Medical Transcription Billing (NASDAQ:MTBC) Frequently Asked Questions

What is Medical Transcription Billing's stock symbol?

Medical Transcription Billing trades on the NASDAQ under the ticker symbol "MTBC."

How were Medical Transcription Billing's earnings last quarter?

Medical Transcription Billing Corp (NASDAQ:MTBC) released its quarterly earnings results on Wednesday, August, 7th. The technology company reported ($0.19) EPS for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.19). The technology company had revenue of $16.75 million for the quarter, compared to analyst estimates of $15.33 million. Medical Transcription Billing had a negative net margin of 9.21% and a negative return on equity of 17.50%. View Medical Transcription Billing's Earnings History.

When is Medical Transcription Billing's next earnings date?

Medical Transcription Billing is scheduled to release their next quarterly earnings announcement on Wednesday, November 6th 2019. View Earnings Estimates for Medical Transcription Billing.

What guidance has Medical Transcription Billing issued on next quarter's earnings?

Medical Transcription Billing issued an update on its FY 2019 earnings guidance on Wednesday, August, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $63-65 million, compared to the consensus revenue estimate of $64.19 million.

What price target have analysts set for MTBC?

2 brokers have issued 1-year target prices for Medical Transcription Billing's shares. Their forecasts range from $6.00 to $6.00. On average, they expect Medical Transcription Billing's stock price to reach $6.00 in the next year. This suggests a possible upside of 42.9% from the stock's current price. View Analyst Price Targets for Medical Transcription Billing.

What is the consensus analysts' recommendation for Medical Transcription Billing?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medical Transcription Billing in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medical Transcription Billing.

Has Medical Transcription Billing been receiving favorable news coverage?

Press coverage about MTBC stock has been trending somewhat negative recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Medical Transcription Billing earned a media sentiment score of -1.3 on InfoTrie's scale. They also gave news coverage about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Medical Transcription Billing.

Are investors shorting Medical Transcription Billing?

Medical Transcription Billing saw a decline in short interest in the month of August. As of August 31st, there was short interest totalling 200,900 shares, a decline of 5.6% from the July 31st total of 212,900 shares. Based on an average daily trading volume, of 34,800 shares, the short-interest ratio is currently 5.8 days. Approximately 3.3% of the shares of the company are short sold. View Medical Transcription Billing's Current Options Chain.

Who are some of Medical Transcription Billing's key competitors?

What other stocks do shareholders of Medical Transcription Billing own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Transcription Billing investors own include BlackBerry (BB), NVIDIA (NVDA), Sophiris Bio (SPHS), Verastem (VSTM), Microbot Medical (MBOT), Micron Technology (MU), Alibaba Group (BABA), Advanced Micro Devices (AMD), Etsy (ETSY) and Interpace Diagnostics Group (IDXG).

How do I buy shares of Medical Transcription Billing?

Shares of MTBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Medical Transcription Billing's stock price today?

One share of MTBC stock can currently be purchased for approximately $4.20.

How big of a company is Medical Transcription Billing?

Medical Transcription Billing has a market capitalization of $50.54 million and generates $50.55 million in revenue each year. The technology company earns $-2,140,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis. Medical Transcription Billing employs 2,400 workers across the globe.View Additional Information About Medical Transcription Billing.

What is Medical Transcription Billing's official website?

The official website for Medical Transcription Billing is

How can I contact Medical Transcription Billing?

Medical Transcription Billing's mailing address is 7 CLYDE ROAD, SOMERSET NJ, 08873. The technology company can be reached via phone at 732-873-5133.

MarketBeat Community Rating for Medical Transcription Billing (NASDAQ MTBC)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  195 (Vote Outperform)
Underperform Votes:  204 (Vote Underperform)
Total Votes:  399
MarketBeat's community ratings are surveys of what our community members think about Medical Transcription Billing and other stocks. Vote "Outperform" if you believe MTBC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTBC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/24/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel